The Partnership to Advance Clinical electronic Research (PACeR) is a broad-based health care collaborative to provide the next generation of clinical research for new medicines. PACeR brings together global health care organizations and health care experts to share the task of creating and sustaining efficient processes to help more quickly and easily match patients with clinical trials. These organizations include global hospitals, HIT, and pharmaceutical companies.
PACeR will also work with standards and regulatory-based organizations, including the Food and Drug Administration, Clinical Data Interchange Standards Consortium, and Health Level-7.
PACeR is focused on patient benefit, recognizing the importance of adhering to strict safeguards to protect patients' interests, including safety, quality, individualized care, privacy, and access to timely care. PACeR will work closely with the participating medical centers to assess current data capabilities and leverage the opportunities presented to integrate clinical trial elements into electronic clinical records repositories.
By working in concert with all stakeholders, the PACeR collaborative will be on the leading edge of defining, driving, and realizing the benefits of change, in the interest of current and future patients.
Clinical research depends on the identification of eligible candidates to enroll in trials. Due to limited access to standardized data, the identification of patients is a time consuming challenge. Further complicating the process, enrolled candidates may ultimately be dropped from a trial because of subsequent ineligibility findings, geographic limitations, or financial challenges incurred by patients for travel and time lost from work. As patients drop from a trial, new patients must be recruited, causing delays in getting life-saving therapies to market and exponentially increasing the cost of trials.
The PACeR collaborative will be the first coordinated effort to improve timeliness and maximize research capacity through the enhancement and availability of standardized data and research protocols. The PACeR collaborative will seek to streamline and accelerate clinical research processes by providing an improved clinical network approach to support evidence-based drug studies. The resulting products developed for pharmaceutical research will be equally useful for other forms of clinical evidence-based research, such as determining the best therapy to treat individual patients for cancer, diabetes, and other diseases.
What PACeR Will Achieve
PACeR will deliver significant benefits for patients, providers, and other health care sector participants, including:
- Accelerating the process of delivering new medicines to patients
- Improving the efficiency and efficacy of research conducted by academic medical centers
- Improving the ability of information technology companies to understand patient and provider needs, resulting in enhanced system offerings
- Increasing the return on investment for pharmaceutical research resources
- Augmenting New York State's unique position as the global epicenter for medical research
Information and Press
A Broad-Based Health Care Collaborative
to Provide the Next Generation of Clinical
Research for New Medicines Download Full Press Release